Oscar Health Q3 Earnings Crush Estimates, Raises 2026 Guidance
lulegacy · November 7, 2026
Key takeaways
- Oscar Health posted $0.49 EPS vs. an expected loss, with revenue up 72% year-over-year to $5.14 billion.
- The company raised its 2026 earnings guidance for the third time this year, now targeting $850M-$950M.
- Membership grew 27% to 2.7 million, with expansion into new markets and products planned for 2027.
What Happened Oscar Health (NYSE: OSCR) just dropped a third-quarter earnings report that blew past expectations. The health insurer posted $0.49 earnings per share — way ahead of the ($0.14) loss analysts had penciled in. Revenue hit $5.14 billion, topping estimates of $4.69 billion, and marking a 72.1% jump year-over-year. A year ago, Oscar was still posting losses (($0.53) EPS). Now it's not just profitable — it's thriving.
Why the Numbers Look So Good A few things are driving this turnaround. Oscar's medical loss ratio (how much it spends on claims vs. premiums) improved to 84%, and its SG&A expense ratio dropped to a company-record 14%. Translation: Oscar is getting more efficient at running its business, thanks to pricing discipline, tighter cost controls, and tech/AI investments streamlining operations behind the scenes.
Membership also grew 27% year-over-year to 2.7 million, meaning more people are signing up and the company is spreading its fixed costs across a bigger base — a classic scale advantage.
The Guidance Raise Here's the headline move: Oscar bumped up its full-year 2026 earnings-from-operations guidance for the third time this year, now targeting $850 million to $950 million. Through nine months, the company has already banked $1.2 billion in net income and $1.3 billion in earnings from operations. That's a confident signal from management that the good results aren't a one-quarter fluke.
What's Next for Oscar Oscar is leaning into growth, not just efficiency. It's entering open enrollment across 713 counties, including a brand-new South Carolina market, and expanding products like RetireEase and CHOICE. Its digital platform, Lucie, is projected to sell roughly 800,000 policies in 2027 — a sign Oscar is betting on tech-driven distribution to keep scaling.
Looking ahead, management expects the overall ACA marketplace to stay roughly flat in membership next year, but Oscar wants to grow its slice of that pie. It's planning an average rate increase of about 14% for 2027, reflecting rising medical costs across the industry.
The Bottom Line Oscar Health went from a company investors worried about to one posting record efficiency and raising guidance three times in a year. Whether that momentum holds depends on execution in a competitive, cost-sensitive ACA marketplace — but for now, the numbers are telling a strong turnaround story.
Why it matters
Oscar Health's turnaround shows how ACA marketplace insurers can hit profitability through scale, tech, and cost discipline — useful context for investors tracking healthcare stocks or consumers watching ACA premium trends ahead of 2027 enrollment.
Want deals on what you love?
Val finds local offers matched to your interests — free to start.
Meet Val